Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis

IntroductionVasomotor symptoms, or hot flashes, are among the most common complaints for menopausal and postmenopausal women. As an alternative to hormone replacement therapy, paroxetine mesylate became the only non-hormonal treatment approved by the U.S. Food and Drug Administration (FDA), despite...

Full description

Bibliographic Details
Published in:Frontiers in Psychiatry
Main Authors: Joshua R. Rhodes, Cameron T. Alldredge, Gary R. Elkins
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1204163/full